79 related articles for article (PubMed ID: 7787700)
1. [The pharmacokinetics of the new Russian prolonged-action form of diclofenac sodium--Ortopek--in a single oral dose].
Kurapov AP; Starodubtsev AK; Rubtsova TM; Ignat'ev VG; Kemenova VA
Eksp Klin Farmakol; 1995; 58(1):53-4. PubMed ID: 7787700
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
Raz I; Hussein Z; Samara E; Ben-David J
Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
[TBL] [Abstract][Full Text] [Related]
3. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.
Paton DM
Int J Clin Pharmacol Res; 1987; 7(4):239-42. PubMed ID: 3596865
[TBL] [Abstract][Full Text] [Related]
6. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacology of the new Soviet anti-inflammatory preparation ortofen].
Kukes VG; Murashko VV; Iagunina MV; Volchenok VI; Pokryshkin VI
Ter Arkh; 1988; 60(3):105-9. PubMed ID: 3388258
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic studies in healthy volunteers on a new gastroprotective pharmaceutic form of diclofenac.
De Bernardi di Valserra M; Feletti F; Tripodi AS; Contos S; Carabelli A; Maggi L; Germogli R
Arzneimittelforschung; 1993 Mar; 43(3):373-7. PubMed ID: 8489569
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
Alsarra IA
Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
[TBL] [Abstract][Full Text] [Related]
11. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
Hasan MM; Najib NM; Muti H
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of diclofenac sodium in normal man.
Hasan SM; Ahmed T; Talib N; Hasan F
Pak J Pharm Sci; 2005 Jan; 18(1):18-24. PubMed ID: 16431378
[TBL] [Abstract][Full Text] [Related]
13. A two-way cross-over bioequivalence study comparing two products of diclofenac sodium suppositories in healthy human volunteers.
Hasan M; Otoom S; Najib N; Sallam el-S
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):263-5. PubMed ID: 15569270
[TBL] [Abstract][Full Text] [Related]
14. Determination of diclofenac in micro-whole blood samples by high-performance liquid chromatography with electrochemical detection. Application in a pharmacokinetic study.
Torres-López JE; Robles MB; Pérez-Urizar J; Flores-Murrieta FJ; Granados-Soto V
Arzneimittelforschung; 1997 Sep; 47(9):1040-3. PubMed ID: 9342419
[TBL] [Abstract][Full Text] [Related]
15. Diclofenac sodium: blood concentration of the slow-release form and influence on the metabolism of kallikrein.
Gross W; Kroh J; Krebs A; Zöller H
Arzneimittelforschung; 1984; 34(10):1327-9. PubMed ID: 6335038
[TBL] [Abstract][Full Text] [Related]
16. PHARMACOKINETICS OF DICLOFENAC SODIUM AND PAPAVERINE HYDROCHLORIDE AFTER ORAL ADMINISTRATION OF TABLETS TO RABBITS.
Kasperek R; Zimmer Ł; Jawień W; Poleszak E
Acta Pol Pharm; 2015; 72(3):527-38. PubMed ID: 26642661
[TBL] [Abstract][Full Text] [Related]
17. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
Ramakrishna S; Fadnavis NW; Diwan PV
Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
[TBL] [Abstract][Full Text] [Related]
20. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
